Breast cancer as a systemic disease: a view of metastasis

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era

(2013) Erin M. Olson et al.   BREAST

Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis

(2013) Pallavi Chaturvedi et al.   JOURNAL OF CLINICAL INVESTIGATION

Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience

(2013) Lorenzo Livi et al.   MEDICAL ONCOLOGY

Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer†

(2012) Y. Fan et al.   ANNALS OF ONCOLOGY

Aspirin and cancer risk: a quantitative review to 2011

(2012) C. Bosetti et al.   ANNALS OF ONCOLOGY

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome

(2012) Kjersti Tjensvoll et al.   BMC CANCER

Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer

(2012) Johanna Tuomela et al.   BREAST CANCER RESEARCH AND TREATMENT

Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer

(2012) Veronique M. Neumeister et al.   BREAST CANCER RESEARCH AND TREATMENT

The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform

(2012) M-h Chong et al.   BRITISH JOURNAL OF CANCER

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma

(2012) S H Sim et al.   BRITISH JOURNAL OF CANCER

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response

(2012) J W Thoms et al.   BRITISH JOURNAL OF CANCER

Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients

(2012) R E Payne et al.   BRITISH JOURNAL OF CANCER

Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases

(2012) Laurien D. C. Hoefnagel et al.   CANCER

Estrogen Promotes ER-Negative Tumor Growth and Angiogenesis through Mobilization of Bone Marrow-Derived Monocytes

(2012) V. Iyer et al.   CANCER RESEARCH

Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer

(2012) Ugo De Giorgi et al.   Clinical Breast Cancer

Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer

(2012) Elisabetta Munzone et al.   Clinical Breast Cancer

Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

(2012) L. Zhang et al.   CLINICAL CANCER RESEARCH

Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence

(2012) Xuehong Zhang et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

(2012) Linda Sofie Lindström et al.   JOURNAL OF CLINICAL ONCOLOGY

Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer

(2012) Farbod Shojaei et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Invasive lobular carcinoma predicts micrometastasis in breast cancer

(2012) Sarah M. Gainer et al.   JOURNAL OF SURGICAL RESEARCH

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors

(2012) Marco Montagner et al.   NATURE

Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor

(2012) R. Macfarlane et al.   ONCOLOGIST

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines

(2012) Ashley A. Powell et al.   PLoS One

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas

(2012) Wen-Hung Kuo et al.   PLoS One

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

(2012) Balaji Krishnamachary et al.   PLoS One

Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells

(2012) L. Schito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

(2012) R. J. Leary et al.   Science Translational Medicine

New insights into the mechanisms of organ-specific breast cancer metastasis

(2012) Girieca Lorusso et al.   SEMINARS IN CANCER BIOLOGY

Molecular networks that regulate cancer metastasis

(2012) Daniela Spano et al.   SEMINARS IN CANCER BIOLOGY

Identification of Luminal Breast Cancers That Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells

(2012) H. S. Kuznetsov et al.   Cancer Discovery

Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients

(2011) Brigitte Rack et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

(2011) Rodrigo Dienstmann et al.   DRUG SAFETY

Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study

(2011) P. Sanpaolo et al.   EJSO

Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice

(2011) Moshe Elkabets et al.   JOURNAL OF CLINICAL INVESTIGATION

Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?

(2011) Katrien De Bock et al.   Nature Reviews Clinical Oncology

Quantitative High-Resolution Genomic Analysis of Single Cancer Cells

(2011) Juliane Hannemann et al.   PLoS One

Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

(2010) Romano Demicheli et al.   BMC CANCER

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

(2010) Savitri Krishnamurthy et al.   CANCER

Molecular mechanisms underlying tumor dormancy

(2010) Nava Almog   CANCER LETTERS

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

The granulin gene family: from cancer to dementia

(2009) Andrew Bateman et al.   BIOESSAYS

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

(2009) Jorma J. de Ronde et al.   BREAST CANCER RESEARCH AND TREATMENT

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systemic Spread Is an Early Step in Breast Cancer

(2008) Yves Hüsemann et al.   CANCER CELL

Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin

(2008) Sandra S. McAllister et al.   CELL

Tumor dormancy due to failure of angiogenesis: role of the microenvironment

(2008) George N. Naumov et al.   CLINICAL & EXPERIMENTAL METASTASIS

Evolution of Bevacizumab-Based Therapy in the Management of Breast Cancer

(2008) Jasgit C. Sachdev et al.   Clinical Breast Cancer